SlideShare a Scribd company logo
MICRORNA-21 AND PTEN: A SIMPLE
PREDICTIVE MODEL FOR FIBROSIS IN CHC
PATIENTS.
Soumya J. Chowdhury*1, Vijay Karra1, Phani Gumma1, Premashis
Kar1
1Medicine, Maulana Azad Medical College, New Delhi,India, New
Delhi, India
OP044
There are no relevant and potential conflicts of interest.
Disclosure statement
CHRONIC HEPATITIS C AND FIBROSIS
 Hepatitis C virus (HCV) continues to be a major disease burden on the
world.
The worldwide estimated prevalence is about 3% .
The noted prevalence of hepatitis C in India is <2% .
Prospective studies have shown that 60 to 85 % of HCV-infected persons
develop chronic infection.
Fibrosis or scarring arises as a result of wound repair and leads to
cirrhosis, nodule formation, altered hepatic function and risk of liver-related
morbidity and mortality.
There has been evidences that fibrosis progression correlates with host
factors more than viral factors.
PTEN : ITS ROLE AND REGULATION
 PTEN- Phosphatase And Tensin-Like protein. Recommended name is
Phosphatidylinositol-3,4,5-triphosphate-3-phosphatase and dual
specificity protein phosphatse PTEN
 Regulates intracellular levels of Phosphatidylinositol-3,4,5-
triphosphate in cells and acts as a tumor suppressor by negatively
regulating AKT/PKB signaling.
 Expression or function of PTEN has found to be regulated by factors
like core proteins of HCV, micro RNA and have found to be involved in
many carcinoma.
Micro RNA are small RNAs that regulate gene expression and are
evolving as clinical predictors for diagnosis and progression of human
disease.
AIM
Finding correlation between increasing fibrosis and variables like
PTEN, miR-21, HCV RNA levels, HCV genotype and other biochemical
parameters
To draw a prediction model out of variables significantly affecting the
dependable variables.
METHODS
Study consisted of 84 CHC patients whose miR-21, PTEN expression, HCV
RNA levels were estimated by Real Time QPCR.
76 Healthy blood donors were selected randomly and were evaluated for
any history of liver disease.
All the CHC patients had undergone liver biopsy and were grouped into 3
fibrosis group, viz. ‘F0’ (Fibrosis score 0), ‘FM’(Fibrosis 1& 2), ‘FH’
(Fibrosis ≥3).
Statistical analysis was carried out using SPSS version 20.
RESULTS
 The average age (Mean±S.D) of CHC and control group was
42.55±11.258 and 33.42±6.293 years respectively.
The mRNA expression levels of PTEN was 11.32 fold reduced in
disease group when compared to healthy (p<0.001).
The miR-21 expression levels was increased 1.5 folds in disease group
when compared to healthy group (p<0.001).
 Univariate analysis and post-hoc analysis revealed following results
 The Total Bilirubin was significantly different between ‘FM’ and
‘FH’ (0.7±0.306 and 1.13±.563; p=0.014)
miR-21 expression levels were significantly different in ‘F0’,’FM’
and ‘FH’ group. ‘FH’ group had 2.3 fold and 4.5 fold increase in
expression when compared to ‘FM’ and ‘F0’ respectively. The ‘FM’
group had 1.9 fold increased expression than the ‘F0’ group.
PTEN expression was significantly higher in ‘FH’ group than the
‘FM’ and ‘F0’ group.
RESULTS (CONTD..)
Multinominal logistic regression was done to find out the predictor of
increasing fibrosis with above variables and It was found that only
PTEN(2
∆Cp
) predicted FH from FM with statistical significance (B=-
1.5,p<0.0001).
Multiple regression was carried out to predict PTEN(2
∆Cp
) from T.Bil and
miR21(2
∆Cp
).
 T.Bil and miR21(2
∆Cp
) added statistically significantly to the
prediction model
Regression equation:
PTEN(2
∆Cp
)=40.63-(13.85xmi21a(2
∆Cp
))+(10.65xT.Bil)
Using this model new cut-off value of PTEN(2
∆Cp
) was calculated using
ROC.
 AUC was 0.983
cut-off level >24.22 was found to predict higher fibrosis with
sensitivity of 92.86% and Specificity of 89.29%.
It had a PPV of 82.35% and NPV of 100%
CONCLUSION
Decrease in PTEN mRNA expression is significantly associated
with increase in fibrosis.
PTEN expression and miR-21 expression are negatively
correlated.
Other than PTEN expression,miR-21 expression and Total
Bilirubin, non other factor correlate to fibrosis.
 New score of >24.22 of PTEN from the equation
PTEN(2
∆Cp
)=40.63-(13.85xmi21a(2
∆Cp
))+(10.65xT.Bil) can be used for
predicting higher fibrosis.

More Related Content

What's hot

Follicular lymphoma
Follicular lymphomaFollicular lymphoma
Follicular lymphoma
hatem honor
 
Sorafenib
SorafenibSorafenib
Sorafenib
3s4num
 
Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...
Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...
Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...
Clinical Surgery Research Communications
 
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
Clinical Surgery Research Communications
 
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MDMolecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
rick435
 
Antiangiogenic therapy in colorectal cancer
Antiangiogenic therapy in colorectal cancerAntiangiogenic therapy in colorectal cancer
Antiangiogenic therapy in colorectal cancer
Mohamed Abdulla
 
04 rencontres biomédicale LIR Philippe Froguel
04 rencontres biomédicale LIR Philippe Froguel04 rencontres biomédicale LIR Philippe Froguel
04 rencontres biomédicale LIR Philippe Froguel
Association LIR
 
New developments of targeted therapy in nsclc
New developments of targeted therapy in nsclcNew developments of targeted therapy in nsclc
New developments of targeted therapy in nsclc
lihua jiao
 
Dissertation Final Draft
Dissertation Final DraftDissertation Final Draft
Dissertation Final Draft
James Pereira
 
G. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the artG. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the art
European School of Oncology
 
Targeted therapy in lung cancer
Targeted therapy in lung cancerTargeted therapy in lung cancer
Targeted therapy in lung cancer
Shriram Shenoy
 
1476-4598-2-38
1476-4598-2-381476-4598-2-38
1476-4598-2-38
Christian Schmidt
 
Success story of m tor inhibitors in m rcc
Success story of m tor inhibitors in m rccSuccess story of m tor inhibitors in m rcc
Success story of m tor inhibitors in m rcc
Mohamed Abdulla
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
European School of Oncology
 
Inherited T790M EGFR Mutation and Lung Cancer Risk
Inherited T790M EGFR Mutation and Lung Cancer RiskInherited T790M EGFR Mutation and Lung Cancer Risk
Inherited T790M EGFR Mutation and Lung Cancer Risk
H. Jack West
 
MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...
MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...
MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...
European School of Oncology
 
What is car t pipeline
What is car t pipelineWhat is car t pipeline
What is car t pipeline
DelveInsight Business Research
 
Cáncer gástrico
Cáncer gástricoCáncer gástrico
Role of EGFR in lung cancer:Resistance and Treatment
Role of EGFR in lung cancer:Resistance and TreatmentRole of EGFR in lung cancer:Resistance and Treatment
Role of EGFR in lung cancer:Resistance and Treatment
Girisha Maheshwari
 
ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...
ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...
ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...
European School of Oncology
 

What's hot (20)

Follicular lymphoma
Follicular lymphomaFollicular lymphoma
Follicular lymphoma
 
Sorafenib
SorafenibSorafenib
Sorafenib
 
Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...
Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...
Lnc rna h19 induces retinal müller cell apoptosis via mir-29b foxo4 axis in d...
 
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
 
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MDMolecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
 
Antiangiogenic therapy in colorectal cancer
Antiangiogenic therapy in colorectal cancerAntiangiogenic therapy in colorectal cancer
Antiangiogenic therapy in colorectal cancer
 
04 rencontres biomédicale LIR Philippe Froguel
04 rencontres biomédicale LIR Philippe Froguel04 rencontres biomédicale LIR Philippe Froguel
04 rencontres biomédicale LIR Philippe Froguel
 
New developments of targeted therapy in nsclc
New developments of targeted therapy in nsclcNew developments of targeted therapy in nsclc
New developments of targeted therapy in nsclc
 
Dissertation Final Draft
Dissertation Final DraftDissertation Final Draft
Dissertation Final Draft
 
G. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the artG. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the art
 
Targeted therapy in lung cancer
Targeted therapy in lung cancerTargeted therapy in lung cancer
Targeted therapy in lung cancer
 
1476-4598-2-38
1476-4598-2-381476-4598-2-38
1476-4598-2-38
 
Success story of m tor inhibitors in m rcc
Success story of m tor inhibitors in m rccSuccess story of m tor inhibitors in m rcc
Success story of m tor inhibitors in m rcc
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
 
Inherited T790M EGFR Mutation and Lung Cancer Risk
Inherited T790M EGFR Mutation and Lung Cancer RiskInherited T790M EGFR Mutation and Lung Cancer Risk
Inherited T790M EGFR Mutation and Lung Cancer Risk
 
MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...
MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...
MCO 2011 - Slide 20 - R.A. Stahel - Spotlight session - New drugs in oncogeni...
 
What is car t pipeline
What is car t pipelineWhat is car t pipeline
What is car t pipeline
 
Cáncer gástrico
Cáncer gástricoCáncer gástrico
Cáncer gástrico
 
Role of EGFR in lung cancer:Resistance and Treatment
Role of EGFR in lung cancer:Resistance and TreatmentRole of EGFR in lung cancer:Resistance and Treatment
Role of EGFR in lung cancer:Resistance and Treatment
 
ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...
ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...
ABC1 - R. Wuerstlein - Primary tumor in breast cancer and phenotype in positi...
 

Similar to presentation

全人關懷獎的簡報
全人關懷獎的簡報全人關懷獎的簡報
全人關懷獎的簡報
bgbgbg
 
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
semualkaira
 
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
semualkaira
 
2710801
27108012710801
2710801
HardikBhatt51
 
Procalcitonin
ProcalcitoninProcalcitonin
Procalcitonin
nazuk sharma
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
ucrheumatologyfellowship
 
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Erwin Chiquete, MD, PhD
 
A Comparative Group Of Healthy Controls
A Comparative Group Of Healthy ControlsA Comparative Group Of Healthy Controls
A Comparative Group Of Healthy Controls
Stephanie Clark
 
Nrgastro.2012.208
Nrgastro.2012.208Nrgastro.2012.208
Nrgastro.2012.208
Elsa von Licy
 
IJSRED-V2I1P1
IJSRED-V2I1P1IJSRED-V2I1P1
IJSRED-V2I1P1
IJSRED
 
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2 Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Dr. Aryan (Anish Dhakal)
 
Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...
Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...
Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...
Jagruti Marathe
 
Lombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory SignatureLombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory Signature
degarden
 
PIIS0016508514604509
PIIS0016508514604509PIIS0016508514604509
PIIS0016508514604509
Mariah Baril-Dore
 
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...
science journals
 
9979-152032-3-PB (2)
9979-152032-3-PB (2)9979-152032-3-PB (2)
9979-152032-3-PB (2)
Andrew Hinton
 
Molecular Biology of Esophageal and Gastric Cancer
Molecular Biology of Esophageal and Gastric CancerMolecular Biology of Esophageal and Gastric Cancer
Molecular Biology of Esophageal and Gastric Cancer
Siddharth Sreemahadevan
 
W5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection JayaweeraW5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection Jayaweera
DSHS
 
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
European School of Oncology
 
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
JohnJulie1
 

Similar to presentation (20)

全人關懷獎的簡報
全人關懷獎的簡報全人關懷獎的簡報
全人關懷獎的簡報
 
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
 
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
 
2710801
27108012710801
2710801
 
Procalcitonin
ProcalcitoninProcalcitonin
Procalcitonin
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
 
A Comparative Group Of Healthy Controls
A Comparative Group Of Healthy ControlsA Comparative Group Of Healthy Controls
A Comparative Group Of Healthy Controls
 
Nrgastro.2012.208
Nrgastro.2012.208Nrgastro.2012.208
Nrgastro.2012.208
 
IJSRED-V2I1P1
IJSRED-V2I1P1IJSRED-V2I1P1
IJSRED-V2I1P1
 
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2 Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
 
Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...
Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...
Investigation of Long term Hazards and Multi organ Impact of SARS COV-2 in Po...
 
Lombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory SignatureLombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory Signature
 
PIIS0016508514604509
PIIS0016508514604509PIIS0016508514604509
PIIS0016508514604509
 
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...
 
9979-152032-3-PB (2)
9979-152032-3-PB (2)9979-152032-3-PB (2)
9979-152032-3-PB (2)
 
Molecular Biology of Esophageal and Gastric Cancer
Molecular Biology of Esophageal and Gastric CancerMolecular Biology of Esophageal and Gastric Cancer
Molecular Biology of Esophageal and Gastric Cancer
 
W5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection JayaweeraW5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection Jayaweera
 
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
 
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
 

presentation

  • 1. MICRORNA-21 AND PTEN: A SIMPLE PREDICTIVE MODEL FOR FIBROSIS IN CHC PATIENTS. Soumya J. Chowdhury*1, Vijay Karra1, Phani Gumma1, Premashis Kar1 1Medicine, Maulana Azad Medical College, New Delhi,India, New Delhi, India OP044
  • 2. There are no relevant and potential conflicts of interest. Disclosure statement
  • 3. CHRONIC HEPATITIS C AND FIBROSIS  Hepatitis C virus (HCV) continues to be a major disease burden on the world. The worldwide estimated prevalence is about 3% . The noted prevalence of hepatitis C in India is <2% . Prospective studies have shown that 60 to 85 % of HCV-infected persons develop chronic infection. Fibrosis or scarring arises as a result of wound repair and leads to cirrhosis, nodule formation, altered hepatic function and risk of liver-related morbidity and mortality. There has been evidences that fibrosis progression correlates with host factors more than viral factors.
  • 4. PTEN : ITS ROLE AND REGULATION  PTEN- Phosphatase And Tensin-Like protein. Recommended name is Phosphatidylinositol-3,4,5-triphosphate-3-phosphatase and dual specificity protein phosphatse PTEN  Regulates intracellular levels of Phosphatidylinositol-3,4,5- triphosphate in cells and acts as a tumor suppressor by negatively regulating AKT/PKB signaling.  Expression or function of PTEN has found to be regulated by factors like core proteins of HCV, micro RNA and have found to be involved in many carcinoma. Micro RNA are small RNAs that regulate gene expression and are evolving as clinical predictors for diagnosis and progression of human disease.
  • 5. AIM Finding correlation between increasing fibrosis and variables like PTEN, miR-21, HCV RNA levels, HCV genotype and other biochemical parameters To draw a prediction model out of variables significantly affecting the dependable variables.
  • 6. METHODS Study consisted of 84 CHC patients whose miR-21, PTEN expression, HCV RNA levels were estimated by Real Time QPCR. 76 Healthy blood donors were selected randomly and were evaluated for any history of liver disease. All the CHC patients had undergone liver biopsy and were grouped into 3 fibrosis group, viz. ‘F0’ (Fibrosis score 0), ‘FM’(Fibrosis 1& 2), ‘FH’ (Fibrosis ≥3). Statistical analysis was carried out using SPSS version 20.
  • 7. RESULTS  The average age (Mean±S.D) of CHC and control group was 42.55±11.258 and 33.42±6.293 years respectively. The mRNA expression levels of PTEN was 11.32 fold reduced in disease group when compared to healthy (p<0.001). The miR-21 expression levels was increased 1.5 folds in disease group when compared to healthy group (p<0.001).  Univariate analysis and post-hoc analysis revealed following results  The Total Bilirubin was significantly different between ‘FM’ and ‘FH’ (0.7±0.306 and 1.13±.563; p=0.014) miR-21 expression levels were significantly different in ‘F0’,’FM’ and ‘FH’ group. ‘FH’ group had 2.3 fold and 4.5 fold increase in expression when compared to ‘FM’ and ‘F0’ respectively. The ‘FM’ group had 1.9 fold increased expression than the ‘F0’ group. PTEN expression was significantly higher in ‘FH’ group than the ‘FM’ and ‘F0’ group.
  • 8. RESULTS (CONTD..) Multinominal logistic regression was done to find out the predictor of increasing fibrosis with above variables and It was found that only PTEN(2 ∆Cp ) predicted FH from FM with statistical significance (B=- 1.5,p<0.0001). Multiple regression was carried out to predict PTEN(2 ∆Cp ) from T.Bil and miR21(2 ∆Cp ).  T.Bil and miR21(2 ∆Cp ) added statistically significantly to the prediction model Regression equation: PTEN(2 ∆Cp )=40.63-(13.85xmi21a(2 ∆Cp ))+(10.65xT.Bil) Using this model new cut-off value of PTEN(2 ∆Cp ) was calculated using ROC.  AUC was 0.983 cut-off level >24.22 was found to predict higher fibrosis with sensitivity of 92.86% and Specificity of 89.29%. It had a PPV of 82.35% and NPV of 100%
  • 9. CONCLUSION Decrease in PTEN mRNA expression is significantly associated with increase in fibrosis. PTEN expression and miR-21 expression are negatively correlated. Other than PTEN expression,miR-21 expression and Total Bilirubin, non other factor correlate to fibrosis.  New score of >24.22 of PTEN from the equation PTEN(2 ∆Cp )=40.63-(13.85xmi21a(2 ∆Cp ))+(10.65xT.Bil) can be used for predicting higher fibrosis.